This site does not have SSL enabled. Please visit http://ir.immunepharma.com/news/detail/164/immune-pharmaceuticals-receives-positive-opinion-for-orphan-drug-designation-in-the-european-union-for-bertilimumab-for-the-treatment-of-bullous-pemphigoid.